Impact of “day 90” CD4+ T cells on clinical outcomes in children with relapsed/refractory acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
CD4+ T cell count may be used to identify pediatric patients with R/R-AML with a greater mortality risk early after HSCT.
Authors
- Shaoyan Hu (ORCID: https://orcid.org/0000-0002-5183-2259)
- Guihua Shu
- Wei Gao (ORCID: https://orcid.org/0000-0002-4239-3012)
- Shengqin Cheng
- Jing Ling (ORCID: https://orcid.org/0000-0003-3929-140X)
- Jie Li (ORCID: https://orcid.org/0000-0003-0973-8645)
- Bohan Li (ORCID: https://orcid.org/0000-0003-2952-146X)
- Jin Yang (ORCID: https://orcid.org/0000-0002-0715-3371)
- Qin Lu (ORCID: https://orcid.org/0000-0002-6829-3394)
- Jun Lu (ORCID: https://orcid.org/0000-0002-6740-6828)
- Wei Jing (ORCID: https://orcid.org/0000-0001-8054-0725)
- Peifang Xiao (ORCID: https://orcid.org/0000-0002-8237-7930)
Institutions
- Soochow University (CN)
- Northern Jiangsu People's Hospital (CN)
- Children's Hospital of Suzhou University (CN)
- Hezhou University (CN)
Publication Details
- Journal
- Transplant Immunology
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1016/j.trim.2024.102112
- Citations
- 2
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.91